An Indian generic drug, which has got regulatory approvals in the US, Britain, EU, Canada and Australia, can now access the Singapore market without going through the same process again. view more news..
Wednesday, May 12, 2010
Subscribe to:
Post Comments (Atom)





No comments:
Post a Comment